Annual CFI
$10.40 M
+$10.40 M+100.00%
31 December 2023
Summary:
Cyclerion Therapeutics annual cash flow from investing activities is currently $10.40 million, with the most recent change of +$10.40 million (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$10.38 million (+57688.89%). CYCN annual CFI is now at all-time high.CYCN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$10.40 million (-100.00%). CYCN quarterly CFI is now -100.00% below its all-time high of $10.40 million, reached on 30 September 2023.CYCN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$0.00
-$10.40 M-100.00%
30 September 2024
Summary:
Cyclerion Therapeutics TTM cash flow from investing activities is currently $0.00, with the most recent change of -$10.40 million (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$10.40 million (-100.00%). CYCN TTM CFI is now -100.00% below its all-time high of $10.40 million, reached on 30 September 2023.CYCN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | -100.0% | -100.0% |
| 3 y3 years | +10000.0% | +100.0% | -100.0% |
| 5 y5 years | +402.6% | +100.0% | +100.0% |
CYCN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | -100.0% | +100.0% | -100.0% | ||
| 5 y | 5 years | at high | +254.9% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | at high | +254.9% | -100.0% | +100.0% | -100.0% | +100.0% |
Cyclerion Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2024 | - | $0.00(0.0%) | $10.40 M(0.0%) |
| Dec 2023 | $10.40 M(>+9900.0%) | $0.00(-100.0%) | $10.40 M(0.0%) |
| Sept 2023 | - | $10.40 M(>+9900.0%) | $10.40 M(>+9900.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2021 | $1.46 M(+7994.4%) | $0.00(-100.0%) | $1.46 M(-49.6%) |
| Sept 2021 | - | -$7000.00(-450.0%) | $2.89 M(-0.3%) |
| June 2021 | - | $2000.00(-99.9%) | $2.90 M(+2.4%) |
| Mar 2021 | - | $1.46 M(+1.8%) | $2.84 M(>+9900.0%) |
| Dec 2020 | $18.00 K | $1.44 M(>+9900.0%) | $18.00 K(-101.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $3000.00(-104.6%) | -$1.52 M(-26.8%) |
| June 2020 | - | -$65.00 K(-95.2%) | -$2.08 M(-66.8%) |
| Mar 2020 | - | -$1.36 M(+1256.0%) | -$6.26 M(-6.8%) |
| Dec 2019 | -$6.71 M(+95.3%) | -$100.00 K(-81.9%) | -$6.71 M(-20.4%) |
| Sept 2019 | - | -$554.00 K(-87.0%) | -$8.43 M(-6.7%) |
| June 2019 | - | -$4.25 M(+134.1%) | -$9.04 M(+77.5%) |
| Mar 2019 | - | -$1.81 M(-0.1%) | -$5.09 M(+48.1%) |
| Dec 2018 | -$3.44 M(+144.9%) | -$1.82 M(+56.6%) | -$3.44 M(+112.0%) |
| Sept 2018 | - | -$1.16 M(+286.7%) | -$1.62 M(+251.1%) |
| June 2018 | - | -$300.00 K(+85.2%) | -$462.00 K(+185.2%) |
| Mar 2018 | - | -$162.00 K | -$162.00 K |
| Dec 2017 | -$1.40 M | - | - |
FAQ
- What is Cyclerion Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual CFI year-on-year change?
- What is Cyclerion Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly CFI year-on-year change?
- What is Cyclerion Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics TTM CFI year-on-year change?
What is Cyclerion Therapeutics annual cash flow from investing activities?
The current annual CFI of CYCN is $10.40 M
What is the all time high annual CFI for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual cash flow from investing activities is $10.40 M
What is Cyclerion Therapeutics annual CFI year-on-year change?
Over the past year, CYCN annual cash flow from investing activities has changed by +$10.40 M (+100.00%)
What is Cyclerion Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of CYCN is $0.00
What is the all time high quarterly CFI for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly cash flow from investing activities is $10.40 M
What is Cyclerion Therapeutics quarterly CFI year-on-year change?
Over the past year, CYCN quarterly cash flow from investing activities has changed by -$10.40 M (-100.00%)
What is Cyclerion Therapeutics TTM cash flow from investing activities?
The current TTM CFI of CYCN is $0.00
What is the all time high TTM CFI for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high TTM cash flow from investing activities is $10.40 M
What is Cyclerion Therapeutics TTM CFI year-on-year change?
Over the past year, CYCN TTM cash flow from investing activities has changed by -$10.40 M (-100.00%)